Please login to the form below

Not currently logged in
Email:
Password:

Lupin

This page shows the latest Lupin news and features for those working in and with pharma, biotech and healthcare.

India denies Vertex patent on cystic fibrosis drug Orkambi

India denies Vertex patent on cystic fibrosis drug Orkambi

The patent was opposed by the Indian Pharmaceutical Alliance (IPA), a trade organisation representing India's larger pharmaceutical companies, including Cipla, Dr Reddy's Labs, Lupin, Nicholas Piramal, Ranbaxy and Wockhardt.

Latest news

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Deal Watch August 2016 Deal Watch August 2016

    165. Shionogi (JP). Kyowa (JP) (Lupin). Asset acquisition Japan. 21 branded products in Japan with $90m sales.

  • Pharma deals in July 2015 Pharma deals in July 2015

    The consolidation in the generics industry has also increased with Lupin's acquisition of the US generics company Gavis for $880m at a high sales multiple of nine but which has ... In July Lupin also acquired a factory in Russia and a speciality product

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Minoyrx Therapeutics appoints chief medical officer Minoyrx Therapeutics appoints chief medical officer

    Minoyrx Therapeutics appoints chief medical officer. Dr Uwe Meya joins from Lupin Atlantis Holdings. ... He joins the Barcelona-based drug development company from Lupin Atlantis Holdings, where he oversaw its clinical strategy and implementation of

  • Lupin appoints Thierry Volle president for EMEA Lupin appoints Thierry Volle president for EMEA

    Lupin appoints Thierry Volle president for EMEA. He moves to the company from Vifor. ... Vinita Gupta, Lupin's chief executive officer, said: "We are delighted to have Thierry join the Lupin family.

  • Dr Maurice Chagnaud appointed as new CEO of Polpharma Dr Maurice Chagnaud appointed as new CEO of Polpharma

    He will join the company next week from Lupin where he was a group president with an inhalation remit for Europe, Russia &CIS. ... We are impressed by the extensive experience of Mr Chagnaud, gained in international companies such as Merck Generics, Teva

  • Lupin names chief corporate development officer Lupin names chief corporate development officer

    Lupin names chief corporate development officer. Theresa Stevens has experience at Novartis and Aptalis. ... Lupin has appointed Theresa Stevens as chief corporate development officer for its global operations.

  • Lupin appoints European president Lupin appoints European president

    Lupin appoints European president. Maurice Chagnaud moves to India-based company from Teva. ... He will also be responsible for developing Lupin's core strategy for inhalation across all developed markets.

More from appointments
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics